Product Name :
NG25
Description:
NG-25 is a type II kinase inhibitor that inhibits MAP4K2 and TAK1. It also inhibits the Src family kinases Src and LYN and Abl family kinases as well as CSK, FER, and p38α. NG 25 prevents TNF-α-induced IKKα/β phosphorylation and IκB-α degradation in L929 cells. It inhibits secretion of IFN-α and IFN-β induced by CpG type B and CL097, respectively. NG 25 decreases cell viability of HCT116KRASWT, and to a greater degree of HCT116KRASG13D, colorectal cancer cells in a concentration-dependent manner. It also reduces tumor growth and increases the number of TUNEL-positive tumor cells in a CT26KRASG12D mouse orthotopic model of colorectal cancer.
CAS:
1315355-93-1
Molecular Weight:
537.58
Formula:
C29H30F3N5O2
Chemical Name:
N-{4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-4-methyl-3-{1H-pyrrolo[2,3-b]pyridin-4-yloxy}benzamide
Smiles :
CC1=CC=C(C=C1OC1C=CN=C2NC=CC=12)C(=O)NC1=CC(=C(CN2CCN(CC2)CC)C=C1)C(F)(F)F
InChiKey:
SMPGEBOIKULBCT-UHFFFAOYSA-N
InChi :
InChI=1S/C29H30F3N5O2/c1-3-36-12-14-37(15-13-36)18-21-6-7-22(17-24(21)29(30,31)32)35-28(38)20-5-4-19(2)26(16-20)39-25-9-11-34-27-23(25)8-10-33-27/h4-11,16-17H,3,12-15,18H2,1-2H3,(H,33,34)(H,35,38)
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥360 days if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
NG-25 is a type II kinase inhibitor that inhibits MAP4K2 and TAK1. It also inhibits the Src family kinases Src and LYN and Abl family kinases as well as CSK, FER, and p38α. NG 25 prevents TNF-α-induced IKKα/β phosphorylation and IκB-α degradation in L929 cells. It inhibits secretion of IFN-α and IFN-β induced by CpG type B and CL097, respectively. NG 25 decreases cell viability of HCT116KRASWT, and to a greater degree of HCT116KRASG13D, colorectal cancer cells in a concentration-dependent manner. It also reduces tumor growth and increases the number of TUNEL-positive tumor cells in a CT26KRASG12D mouse orthotopic model of colorectal cancer.|Product information|CAS Number: 1315355-93-1|Molecular Weight: 537.58|Formula: C29H30F3N5O2|Chemical Name: N-{4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-4-methyl-3-{1H-pyrrolo[2,3-b]pyridin-4-yloxy}benzamide|Smiles: CC1=CC=C(C=C1OC1C=CN=C2NC=CC=12)C(=O)NC1=CC(=C(CN2CCN(CC2)CC)C=C1)C(F)(F)F|InChiKey: SMPGEBOIKULBCT-UHFFFAOYSA-N|InChi: InChI=1S/C29H30F3N5O2/c1-3-36-12-14-37(15-13-36)18-21-6-7-22(17-24(21)29(30,31)32)35-28(38)20-5-4-19(2)26(16-20)39-25-9-11-34-27-23(25)8-10-33-27/h4-11,16-17H,3,12-15,18H2,1-2H3,(H,33,34)(H,35,38)|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{VV116} medchemexpress|{VV116} RSV|{VV116} Biological Activity|{VV116} In Vitro|{VV116} supplier|{VV116} Autophagy} |Shelf Life: ≥360 days if stored properly.{{8-Hydroxy-2′-deoxyguanosine} medchemexpress|{8-Hydroxy-2′-deoxyguanosine} Endogenous Metabolite|{8-Hydroxy-2′-deoxyguanosine} Protocol|{8-Hydroxy-2′-deoxyguanosine} References|{8-Hydroxy-2′-deoxyguanosine} manufacturer|{8-Hydroxy-2′-deoxyguanosine} Epigenetics} |Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.PMID:31085260 |Drug Formulation: To be determined|HS Tariff Code: 382200|Products are for research use only. Not for human use.|